BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7474153)

  • 1. A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence.
    Ramsingh AI; Collins DN
    J Virol; 1995 Nov; 69(11):7278-81. PubMed ID: 7474153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype.
    Caggana M; Chan P; Ramsingh A
    J Virol; 1993 Aug; 67(8):4797-803. PubMed ID: 8392614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic mapping of the determinants of plaque morphology of coxsackievirus B4.
    Ramsingh AI; Caggana M; Ronstrom S
    Arch Virol; 1995; 140(12):2215-26. PubMed ID: 8572942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A point mutation in VP1 of coxsackievirus B4 alters antigenicity.
    Halim S; Ramsingh AI
    Virology; 2000 Mar; 269(1):86-94. PubMed ID: 10725201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence suggesting that virulence maps to the P1 region of the coxsackievirus B4 genome.
    Ramsingh A; Hixson A; Duceman B; Slack J
    J Virol; 1990 Jun; 64(6):3078-81. PubMed ID: 2159563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate sequences that determine virulence in Coxsackievirus B4.
    Ramsingh A; Araki H; Bryant S; Hixson A
    Virus Res; 1992 May; 23(3):281-92. PubMed ID: 1320798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of coxsackievirus virulence.
    Chapman NM; Ramsingh AI; Tracy S
    Curr Top Microbiol Immunol; 1997; 223():227-58. PubMed ID: 9294932
    [No Abstract]   [Full Text] [Related]  

  • 8. Virulence of swine vesicular disease virus is determined at two amino acids in capsid protein VP1 and 2A protease.
    Kanno T; Mackay D; Wilsden G; Kitching P
    Virus Res; 2001 Nov; 80(1-2):101-7. PubMed ID: 11597755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
    Knowlton KU; Jeon ES; Berkley N; Wessely R; Huber S
    J Virol; 1996 Nov; 70(11):7811-8. PubMed ID: 8892902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of tissue tropism determinants in coxsackievirus genomes.
    Harvala H; Kalimo H; Dahllund L; Santti J; Hughes P; Hyypiä T; Stanway G
    J Gen Virol; 2002 Jul; 83(Pt 7):1697-1706. PubMed ID: 12075089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.
    Dunn JJ; Chapman NM; Tracy S; Romero JR
    J Virol; 2000 May; 74(10):4787-94. PubMed ID: 10775617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2A(pro) cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes.
    Mulders MN; Salminen M; Kalkkinen N; Hovi T
    J Gen Virol; 2000 Mar; 81(Pt 3):803-12. PubMed ID: 10675418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.
    Wang Y; Pfeiffer JK
    mBio; 2016 Mar; 7(2):e00119. PubMed ID: 27025249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model.
    Zhang H; Blake NW; Ouyang X; Pandolfino YA; Morgan-Capner P; Archard LC
    Arch Virol; 1995; 140(5):959-66. PubMed ID: 7605207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of coxsackievirus B3 cardiovirulence.
    Tracy S; Tu Z; Chapman N; Hufnagel G
    Eur Heart J; 1995 Dec; 16 Suppl O():15-7. PubMed ID: 8682085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication.
    Seo I; Jee Y; Ahn J; Jun EJ; Kim D; Joo CH; Kim YK; Lee H
    Intervirology; 2007; 50(6):447-53. PubMed ID: 18268408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease.
    Tracy S; Chapman NM; Romero J; Ramsingh AI
    Trends Microbiol; 1996 May; 4(5):175-9. PubMed ID: 8727596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic regions of coxsackievirus B3 associated with cardiovirulence.
    Lee C; Maull E; Chapman N; Tracy S; Gauntt C
    J Med Virol; 1997 Jul; 52(3):341-7. PubMed ID: 9210047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice.
    Tracy S; Höfling K; Pirruccello S; Lane PH; Reyna SM; Gauntt CJ
    J Med Virol; 2000 Sep; 62(1):70-81. PubMed ID: 10935991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coxsackievirus B4: in vitro genetic markers and virulence.
    Jimes S; Jamison RM
    Arch Virol; 1983; 77(1):1-11. PubMed ID: 6312933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.